Skip to main content

Table 1 Summary of clinicopathological data of the enrolled cases

From: Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker

 No. (%)
Age (yrs)Ranged 36 ~  82Mean 63.0 ± 9.4
SexMale 76, Female 50M:F = 1.52:1
Location (tumor epicenter)Original diagnosisRevised diagnosis
 Periampullary duodenum3(2.4%)0(0%)
 AOV37(29.4%)34(27.0%)
 Pancreatic head37(29.4%)44(34.9%)
 Distal CBD47(37.3%)48(38.1%)
 Proximal CBD2(1.6%)0(0%)
T stageOriginal diagnosisRevised diagnosis
 Tis1(0.8%)1(0.8%)
 T121(16.7%)21(16.7%)
 T229(23.0%)29(23.0%)
 T367(53.2%)67(53.2%)
 T48(6.3%)8(6.3%)
Gross type
 Fungating20(15.9%)
 Infiltrative93(73.8%)
 Ulcerofungating3(2.4%)
 Sessile5(4.0%)
 Solid2(1.6%)
Tumor sizeRanged 0.6 ~  8.0 cmMean 3.2 ± 1.6 cm
  < 4.5 cm96(76.2%)
  ≥ 4.5 cm30(23.8%)
N stage
 N073(57.9%)
 N153(42.1%)
 N20(0%)
M stage
 M0117(93.7%)
 M18(6.3%)
 AbsentPresent
Lymphatic invasion70(55.6%)56(44.4%)
Vascular invasion110(87.3%)16(12.7%)
Perineural invasion54(42.9%)72(57.1%)
Positive radial resected margin118(93.7%)8(6.3%)
Tumor ulceration116(92.1%)10(7.9%)
Histologic gradeOriginal diagnosisRevised diagnosis
 Well differentiated37(29.4%)32(25.4%)
 Moderately differentiated79(62.7%)90(71.4%)
 Poorly differentiated10(7.9%)4(3.2%)
Histologic subtype
 Pancreaticobiliary subtype34(27.2%)
 Prone to pancreaticobiliary subtype58(46.4%)
 Prone to intestinal subtype19(15.2%)
 Intestinal subtype14(11.2%)
Degree of fibrosisOriginal diagnosisRevised diagnosis
 Absent4(3.2%)1(0.8%)
 Mild20(15.9%)35(27.8%)
 Moderate72(57.1%)57(45.2%)
 Severe30(23.8%)33(26.2%)
Degree of inflammationOriginal diagnosisRevised diagnosis
 Mild53(42.1%)42(33.3%)
 Moderate62(49.2%)70(55.6%)
 Severe11(8.7%)14(11.1%)
Tumor recurrenceAbsentPresent
 64(51.2%)61(48.8%)
Death39(31.0%)87(69.0%)
Follow-up duration (days)Ranged 3 ~  5234969.7 ± 1135
Disease free survival (days)Ranged 3 ~  4173731.2 ± 954.5